INTRODUCTION
Voltage-gated Ca v 2.1 Ca 2+ channels mediate P/Q-type Ca 2+ currents that control neuronal excitability and neurotransmitter release throughout the nervous system (Catterall, 2000) . The neurophysiological requirement for Ca v 2.1 is illustrated by the severe ataxia, dyskinesia, and absence epilepsy in mice lacking Ca v 2.1 (Jun et al., 1999; Maejima et al., 2013; Mark et al., 2011) . In addition, human mutations in the CACNA1A gene encoding the pore-forming a 1 subunit of Ca v 2.1 (a 1 2.1) cause multiple neurological disorders, including episodic ataxia (Ophoff et al., 1996) , spinocerebellar ataxia (Zhuchenko et al., 1997) , and familial hemiplegic migraine (FHM1) (Ophoff et al., 1996) . Among Ca v channels, Ca v 2.1 exhibits particularly complex behavior and modulation. Single Ca v 2.1 channels can alternate between gating modes characterized by distinct kinetics and voltage-dependent activation Luvisetto et al., 2004) . In addition, Ca v 2.1 channels undergo both positive and negative feedback regulation by Ca 2+ , Ca
2+
-dependent facilitation (CDF), and Ca 2+ -dependent inactivation (CDI), respectively, which contributes to short-term synaptic plasticity Christel and Lee, 2012) . While dihydropyridine analogs have greatly advanced understanding of Ca v 1 channel gating in normal and diseased states (Erxleben et al., 2006; Nowycky et al., 1985) , the scarcity of pharmacological modulators for Ca v 2.1 limits similar mechanistic insights for these channels.
2,5 0 -di(tertbutyl)-1,4,-benzohydroquinone (BHQ) is a synthetic phenolic compound that inhibits sarcoendoplasmic Ca 2+ ATPases (SERCAs) (Moore et al., 1987) and has pro-oxidant properties (Fusi et al., 1999) . Here, we report that, independent of these actions, BHQ inhibits Ca v 2.1 voltage-dependent activation and enhances CDF during high-frequency stimuli. These actions of BHQ ameliorate gating defects in Ca v 2.1 and synaptic transmission due to a S218L mutation in a 1 2.1 that causes a severe form of FHM1 in humans (Kors et al., 2001) . Our results reveal unique features of Ca v 2.1 gating that may be exploited for therapeutic benefit.
RESULTS

BHQ Inhibits Ca v 2.1 Activation and Slows Deactivation
During studies to evaluate the effect of intracellular Ca 2+ on Ca v 2.1 in transfected human embryonic kidney cells transformed with SV40 T-antigen (HEK293T) cells, we discovered modulatory actions of BHQ on Ca v 2.1 properties. BHQ reversibly inhibited Ca v 2.1 Ba 2+ currents (I Ba ) in a dose-dependent manner (half-maximal inhibitory concentration [IC 50 ] of 7.9 ± 1.0 mM; Figures 1A-1C ) and across a range of voltages (Figures 1D and 1E) . To determine the underlying mechanism, we analyzed tail currents, which are evoked by the repolarization-induced change in driving force and reflect the population of open channels at the end of the test depolarization. BHQ suppressed tail currents most strongly at moderate voltages ( Figure S1 available online), which indicated a voltage-dependent mechanism of inhibition rather than a pore-blocking effect. Two-component Boltzmann analysis revealed that the normalized tail currentvoltage curves with BHQ were positively shifted and had a more shallow slope than controls, with BHQ enhancing the component (fraction = F) of I Ba activating at positive voltages (F 2 ; Figure 1F ; Table 1 ). BHQ reduced tail currents to a similar extent and with similar voltage dependence as the steady-state current ( Figure 1G ), which indicated that BHQ inhibits Ca v 2.1 currents primarily by modifying voltage-dependent activation. These effects of BHQ were generally similar for Ca 2+ currents (I Ca ; Figures 1H-1K ). However, unlike I Ba , tail currents for I Ca were best fit by a single Boltzmann function under control conditions and exhibited maximal amplitudes at intermediate voltages. This latter feature has been attributed to CDF, which is particularly prominent for Ca v 2.1 (Chaudhuri et al., 2007) . BHQ introduced a second high-threshold component to the activation curve ( Figure 1J ; Table 1 ). Same as in (D) through (G), except for I Ca . In (H), test pulse (to +20 mV) was 50 ms to achieve steady-state I Ca . In (J), smooth lines represent fits by a single-Boltzmann (for Control) or double-Boltzmann (+BHQ) function; n = 7 cells. All averaged data represent mean ± SEM. See also Figure S1 .
inhibitor, thapsigargin, had no effect on Ca v 2.1 properties (Figure 2A) . BHQ was capable of modestly increasing intracellular Ca 2+ in intact HEK293T cells transfected with Ca v 2.1, as indicated by the ratiometric Ca 2+ indicator, Fura-2 ( Figure 2B ). However, under our whole-cell recording conditions, which included 5 mM EGTA in the intracellular recording solution, BHQ did not produce any change in the level of intracellular Ca 2+ ( Figure 2C ). Therefore, the modulatory effects of BHQ on Ca v 2.1 are independent of SERCA antagonism.
In addition to inhibiting Ca v 2.1 activation, BHQ caused a prominent slowing of deactivation that was evident as a prolongation of the tail currents. For I Ca , the dominant effects of BHQ were a significant increase in the fraction and time constant of a slow component of deactivation ( Figure 3A ). To better understand the modulatory effects of BHQ on inhibiting activation and slowing deactivation, we developed a ten-state model (Figure S2) . According to the model, despite slower deactivation, decreased open probability of channels modulated by BHQ at moderate test voltages would cause the decline in steady-state current amplitude with BHQ ( Figure S2) . Consistent with the model, the proportion of whole-cell I Ca that was inhibited by BHQ was identical to the fraction of the slow tail I Ca across a range of test voltages ( Figure S2 ; p = 1.0, by two-way ANOVA). We conclude that BHQ stabilizes the opening and weakens voltage-dependent activation of Ca v 2.1, which causes slower tail currents and a reduction in the steady-state current, respectively.
BHQ Enhances Ca
2+ -Dependent Facilitation Induced by Action Potential Waveforms Double exponential fits of the tail current decay revealed a significantly larger effect of BHQ on I Ca compared to I Ba . From this analysis, there was no difference in the amplitudes of the slow and fast components (A slow and A fast , respectively) for tail I Ca and tail I Ba , but the slow time constant for tail I Ca decay (6.7 ± 0.8 ms) was significantly greater than that for I Ba (4.8 ± 0.4 ms, p = 0.03; Figure 3B ). The more prominent effect of BHQ on deactivation of I Ca was particularly apparent in plots of the slow tail current amplitude measured 5 ms after repolarization to the holding voltage. At this time point, the current amplitude should be practically devoid of the contribution of the rapidly decaying tail current resulting largely from channels Figure 3C ). The stronger effects of BHQ on deactivation of I Ca compared to I Ba suggested the potential for BHQ to enhance CDF of Ca v 2.1 currents during trains of action potential waveforms (APWs). Due to the short duration (half-width, <1 ms) of APWs and relatively slow activation kinetics of Ca v 2.1, APWs do not evoke significant I Ca during the depolarizing phase but produce large tail currents upon repolarization. During trains of APWs, I Ca undergoes both voltage-dependent facilitation (VDF) (Brody and Yue, 2000; Currie and Fox, 2002) and CDF due to Ca 2+ /calmodulin (Benton and Raman, 2009; Chaudhuri et al., 2007; Kreiner et al., 2010) . In contrast, I Ba exhibits primarily VDF. Because CDF and VDF occur on similar time scales, net CDF is measured as the fractional increase (F CDF ) in the amplitude of I Ca over I Ba at the end of a train of APWs ( Figures 4A-4D ). With this protocol, CDF results in an increase in I Ca (Chaudhuri et al., 2007) , which may be further amplified by BHQ.
To test this, we analyzed the effect of BHQ on I Ca and I Ba during trains of APWs. To restrict analysis to CDF in the absence of the competing effects of CDI, the whole-cell intracellular recording solution contained 5 mM EGTA, which blunts CDI (Figure S3 ) but spares CDF (Lee et al., 2000) . With this protocol, CDF was significantly greater with BHQ (F CDF = 0.25 ± 0.02) than without BHQ (F CDF = 0.17 ± 0.02, p = 0.04; Figures 4B-4D ). To more clearly discern the effect of BHQ on I Ca and I Ba , currents recorded after exposure to BHQ were normalized to the maximal amplitude of the current before bath perfusion with BHQ (i.e., at 0.3 s; F BHQ in Figure 4E ). By this measure, BHQ inhibited I Ba but clearly increased I Ca ( Figure 4E ). The inhibition of I Ba was not due to an effect of BHQ on voltage-dependent inactivation, since BHQ did not enhance the decay of I Ba evoked by a sustained depolarization ( Figure S3 ). When CDF was prevented by coexpression of a calmodulin (CaM) mutant (DeMaria et al., 2001; Lee et al., 2003) , I Ca was not maintained to control levels in the presence of BHQ ( Figure S3 ). Taken together, these results show that BHQ inhibits VDF but also increases CaM-dependent CDF during physiological stimuli.
BHQ Offsets Gain of Function of Ca v 2.1 due to FHM1 Mutation
The S218L mutation enhances voltage-dependent activation of Ca v 2.1, which augments excitatory transmission in S218L knockin (KI) mice (Tottene et al., 2005; van den Maagdenberg et al., 2004 van den Maagdenberg et al., , 2010 . However, S218L also inhibits CDF, which is associated with impaired synaptic plasticity (Adams et al., 2010) . The dual effects of BHQ on inhibiting voltage-dependent activation and enhancing CDF suggested that it could oppose dysfunction associated with the S218L FHM1 mutation in a 1 2.1. To test this, we analyzed the effect of BHQ on I Ca and I Ba in HEK293T cells transfected with S218L-containing channels. As shown elsewhere (Tottene et al., 2005) , I Ba for S218L cells exhibits more negative voltage dependence of activation than wild-type (WT) Ca v 2.1 (Figures 5A and 5B; Table 1 ). Reductions in current density seen with S218L compared to WT (Figure 5A ) may be an artifact of heterologous overexpression, as this is not observed for Ca v 2.1 currents in neurons from KI mice expressing S218L channels (Pietrobon, 2010) . BHQ had similar effects on S218L as on WT channels in inhibiting current density and voltage-dependent activation of I Ba and I Ca (Figures 5C-5H; Table 1 ). Across a physiological voltage range (À30 mV to À10 mV), BHQ offset the enhancement of I Ba caused by the S218L mutation by 25%-44% ( Figure S4 ). Therefore, BHQ reduces the gain of function in Ca v 2.1 caused by S218L.
BHQ Restores CDF Loss of Function due to FHM1 Mutation Similar to its effects on WT channels, BHQ slowed deactivation of S218L (Figures 6A and 6B) . However, this effect of BHQ was greater for S218L than for WT ( Figures 6C and 6D ). Compared to WT channels, BHQ caused a more dramatic shift in the balance of fast and slow fractions of S218L tail I Ca decay, such that total decay was dominated by the slow fraction (A) I Ca was evoked by 15-ms test pulses from À80 mV to various voltages with repolarization to À40 mV under control conditions or in the presence of BHQ (10 mM). Representative current traces are shown (left). For +20 mV to À40 mV step, the decay of tail currents was fit with a double exponential function. Averaged data (mean ± SEM; right) represent the time constant (t) and fractional contribution (Fraction) of the fast and slow component. *p < 0.01 by paired t test. (B) Representative traces for I Ba (left) were evoked as in (A). Averaged data (mean ± SEM; right) show fast and slow time constants from double exponential fits of the decay of tail I Ba (for +10 mV to À40 mV step, n = 10) and I Ca (n = 7) in the presence of BHQ. *p = 0.03 by t test. (C) For I Ca and I Ba evoked as in (A) and (B), tail current amplitudes were measured 5 ms following the repolarization to À40 mV and plotted against test voltage. The percent increase caused by BHQ is indicated for I Ca (at +20 mV) and I Ba (at +10 mV). Points represent mean ± SEM. See also Figure S2 .
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Modulation of Ca v 2.1 Gating by BHQ (0.58 ± 0.02 for S218L versus 0.42 ± 0.05 for WT; p = 0.01 by t test; Figure 6D ). The slow fraction of I Ca decay under control conditions was twice as large for S218L compared to WT (0.16 ± 0.03 for S218L versus 0.08 ± 0.01 for WT, p = 0.03; Figure 6D) . BHQ also increased the slow time constant of I Ca decay for S218L (t slow = 5.3 ± 0.8 ms for control versus 10.2 ± 0.7 ms for BHQ) as it did for WT channels ( Figures 6B and 6D) . These results suggested that BHQ stabilizes a fraction of slowly deactivating channels, which are more prevalent in S218L than WT.
To determine whether BHQ could restore CDF to S218L, we compared I Ca and I Ba evoked by trains of APWs ( Figures 7A-7C ). Because the S218L mutation accelerates fast voltagedependent inactivation of I Ca and I Ba (Tottene et al., 2005; Weiss et al., 2008) , I Ba progressively decreased during the train (Figure 7B) . For this reason, we evaluated I Ca and I Ba during 100 ms trains as opposed to the 300 ms trains used for WT channels ( Figure 4 ). As shown elsewhere (Adams et al., 2010) , S218L did not undergo as much CDF as WT (F CDF = 0.09 ± 0.02 for S218L versus 0.17 ± 0.01 for WT, p = 0.005 by t test; Figures 4D and 7D) . BHQ had a larger effect in enhancing I Ca at the end of the train in S218L compared to WT channels (F BHQ = 1.06 ± 0.01 for S218L at 0.1 s versus 1.02 ± 0.01 for WT at 0.3 s, p = 0.03 by t test; Figures 4E and 7E) and increased CDF for S218L (F CDF = 0.15 ± 0.02), such that it was not different from WT (F CDF = 0.17 ± 0.01; p = 0.63; Figures 4D and 7D ). Taken together, our findings show that BHQ opposes both the enhanced activation and limited CDF of S218L in transfected HEK293T cells.
BHQ Offsets Gain of Function in Synaptic Transmission due to S218L
To determine if BHQ could offset the neurophysiological deficits associated with S218L, we turned to the Drosophila neuromuscular junction (NMJ) as an in vivo model. Here, as in mammals, Ca v 2.1 channels mediate presynaptic Ca 2+ influx that triggers neurotransmitter release (Kawasaki et al., 2000; Macleod et al., 2006; Uchitel et al., 1992) . Subsequent activation of postsynaptic ionotropic glutamate receptors depolarizes the innervated muscle membrane. The resulting excitatory postsynaptic potentials (EPSPs) scale with the amount of neurotransmitter release and promote muscle contraction. Based on previous reports of enhanced transmission at neuromuscular synapses of S218L KI mice , we predicted a similar impact of S218L in Drosophila.
To test this, the mutation analogous to S218L was introduced into the Drosophila ortholog of CACNA1A, cacophony and transgenically expressed in the Drosophila nervous system (''S218L''). The C155-GAL4 (elaV) neuronal driver allowed expression of the transgene in the presynaptic motor neuron but not muscle (Lin and Goodman, 1994) . Compared to controls expressing the WT transgene (''WT''), the amplitude of EPSPs was significantly greater in NMJs expressing the mutant channel (E) The effect of BHQ was measured as the ratio of I norm. in the presence of BHQ to the mean I norm. under control conditions at 0.3 s (F BHQ ; mean ± SEM). For control, n = 17 for I Ca , and n = 8 for I Ba ; for +BHQ, n = 17 for I Ca , and n = 8 for I Ba . See also Figure S3 .
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Modulation of Ca v 2.1 Gating by BHQ (''S218L''; Figure 8A ). This result was not due to increased numbers of synaptic boutons in ''S218L'' versus ''WT,'' which were not significantly different between genotypes (Table 2 ). Analyses of quantal content corrected for nonlinear summation and plotted against different extracellular Ca 2+ concentrations revealed nearly identical Ca 2+ -cooperativity slope values for ''WT'' and ''S218L'' (2.65 and 2.61, respectively). Thus, increased EPSP amplitudes in ''S218L'' are likely due to greater presynaptic Ca 2+ currents mediated by ''S218L'' rather than increases in the Ca 2+ cooperativity of neurotransmitter release.
At 5 mM, BHQ caused nearly $50% inhibition of EPSP amplitudes in ''WT'' NMJs but did not affect miniature EPSP (mEPSP) amplitudes ( Figures 8B and 8C) . These results were consistent with a presynaptic action of BHQ, most likely due to inhibition of Ca v 2.1 activation (Figure 1) . However, this concentration of Figures 1D-1F and 1H-1J but for cells transfected with S218L. Points represent mean ± SEM; n = 12 for I Ba , and n = 10 for I Ca . See also Figure S4 .
BHQ had no effect on EPSP amplitudes in ''S218L'' NMJs. At 10 mM, BHQ strongly inhibited EPSP amplitudes but also affected mEPSPs in both genotypes ( Figures 8B and 8C ). This result suggested an additional effect of BHQ at higher concentrations on spontaneous release properties. Therefore, BHQ at 10 mM reversed the gain of function in synaptic transmission in ''S2l8L'' NMJs, although this effect could not be attributed to actions on Ca v 2.1 alone.
BHQ Restores Synaptic Plasticity
Defect due to S218L Short-term facilitation (STF) of synaptic transmission during bursts of impulses is a form of synaptic plasticity that can be driven by the accumulation of presynaptic Ca 2+ (Zucker and Regehr, 2002) . At cerebellar synapses of S218L KI mice, STF is impaired, which has been attributed to weak CDF of S218L channels (Adams et al., 2009 ). However, a caveat is that basal release probability is inversely related to the magnitude of STF (Zucker and Regehr, 2002) . Therefore, it is also possible that the gain of function of S218L channels would increase basal synaptic transmission, which would subsequently suppress STF in S218L KI mice, independent of any changes in CDF (Adams et al., 2009 ). The fact that BHQ at 5 mM increased CDF of S218L channels in HEK293T cells (Figure 7 ), but did not affect evoked release in ''S218L'' NMJs ( Figures 8B and 8C) , provided an opportunity to determine if weak CDF contributes to the synaptic plasticity defect due to the S218L mutation. If so, this concentration of BHQ should increase STF of ''S218L'' NMJs.
To test this prediction, we analyzed trains of EPSPs evoked by repetitive (10 Hz) stimuli of presynaptic motor neurons. To improve resolution of STF, we initially maintained extracellular Ca 2+ concentrations at 0.4 mM so as not to saturate the release machinery and create problems with nonlinear summation. STF was measured as the amplitude of the evoked EPSPs normalized to that for the initial EPSP of the train (F ratio ). Compared to Figures 9A and 9B ). These results confirm that the synaptic defects that are associated with the S218L mutation van den Maagdenberg et al., 2010) are reproduced by the ''S218L'' at the Drosophila NMJ. BHQ (5 mM) essentially restored STF in ''S218L'' NMJs: there was no significant difference in STF of ''WT'' controls (F ratio at $1 s = 1.22 ± 0.09) and ''S218L'' with BHQ (F ratio at $1 s = 1.20 ± 0.10, p = 0.70; Figures 9A-9C ). This result is consistent with the effects of BHQ in enhancing CDF of S218L in HEK293T cells (Figure 7) . Currents were evoked by 15 ms steps to various voltages from À80 mV before (control) and after exposure to BHQ (+BHQ; 10 mM).
(B) For +10 mV (I Ca ) and 0 mV (I Ba ) test pulses, the decay of tail currents evoked on repolarization to À40 mV was fit with a double exponential function. Averaged data (mean ± SEM) represent the time constant (t) and fractional contribution (Fraction) of the fast and slow components. *p < 0.01 by paired t test; n = 8 for I Ca , and n = 12 for I Ba .
(C and D) Larger effects of BHQ on deactivation of S218L compared to WT channels. Representative traces (C) show I Ca evoked by +20 mV (WT) and +10 mV (S218L) test pulses with repolarization to À40 mV before (control) and after exposure to BHQ (+BHQ; 10 mM). In (D), t slow and F slow were obtained by double exponential fits of tail I Ca obtained as in (C). Data represent mean ± SEM. *p < 0.05 by t test; n = 7 for WT, n = 8 for S218L. To rule out that these effects were due to effects of BHQ on decreasing release probability, we performed similar experiments but with a reduced extracellular concentration of Ca 2+ (0.2 mM; Figures 9B and 9C ). Similar to our results obtained with 0.4 mM Ca 2+ , BHQ (5 mM) did not affect the amplitude of the evoked EPSP in ''S218L'' NMJs (5.5 ± 0.8 mV for control versus 5.4 ± 1.2 mV for BHQ; p = 0.97; Figure 9D ) but still restored STF to the level of the ''WT'' control in 0.2 mM Ca 2+ (Figures 9B and 9C ). This result argues against the likelihood that BHQ restored STF to ''S218L'' simply by inhibiting presynaptic Ca 2+ channels and/or release properties. BHQ did seem to enhance the Ca 2+ cooperativity of release for ''S218L,'' but after normalizing for this effect, BHQ still increased STF to ''WT'' control levels ( Figure S5 ). At a physiological extracellular Ca 2+ concentration (1.5 mM), we observed short-term depression (STD), as opposed to STF for both ''WT'' and ''S218L.'' Despite this difference, BHQ significantly abated STD at early time points without affecting evoked EPSP amplitudes ( Figures 9D and  9E Figures 1D-1K ). While agatoxin IVA speeds deactivation of neuronal Ca v 2.1 channels (McDonough et al., 1997) , BHQ has the opposite effect (Figure 3) . In this regard, BHQ is similar to roscovitine-an inhibitor of cyclin-dependent kinases that also slows deactivation of Ca v 2.1 and Ca v 2.2 channels (Buraei et al., 2005; Yan et al., 2002) . At higher concentrations that involve a kinase-dependent mechanism, roscovitine also inhibits Ca v 2.2 (Buraei et al., 2005) . In contrast, our results indicate that the opposing effects of BHQ on activation and deactivation are mechanistically linked. These modulatory effects may have been missed in previous studies due to the use of high concentrations of BHQ (>100 mM; Fusi et al., 2001; Scamps et al., 2000) that strongly depress current amplitudes ( Figure 1B) . The dual agonist and antagonist actions of BHQ are unique among substances that modulate Ca v 2.1, and should prove useful in mechanistic inquiries into the complex gating properties of these channels.
Modulation of CDF by BHQ: Insights into an Aspect of S218L Gain of Function
During trains of APWs, I Ca in HEK293T cells transfected with Ca v 2.1 may undergo VDF, perhaps due to relief from G-protein 93.0 ± 3.2 (n = 27) 74.5 ± 2.0 (n = 26)
Drosophila larval NMJ fillet preparations were double labeled with antisynapsin and anti-Dlg primary antibodies as described in Experimental Procedures. Synapses for muscle group 6/7 in segments A2 and A3 were examined by immunofluorescence, and synaptic boutons per NMJ 6/7 were counted. For both muscle segments examined, presynaptic expression of ''S218L'' has no significant effect on synapse growth by Student's t test (compared to ''WT,'' p values indicated). Numbers represent synapse counts (mean ± SEM; n = number of synapses counted per genotype). a p = 0.31 for muscle A2 6/7, and p = 0.28 for muscle A3 6/7.
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Modulation of Ca v 2.1 Gating by BHQ inhibition (Brody et al., 1997) , and CDF (Chaudhuri et al., 2007) due to Ca 2+ /CaM binding to the C-terminal domain of the Ca v 2.1 a 1 subunit (DeMaria et al., 2001; Lee et al., 1999 Lee et al., , 2000 . Elementary analyses indicate that both Ca 2+ /CaM and G proteins may stimulate transitions to a gating mode of higher open probability (P o ), but via distinct biophysical pathways (Chaudhuri et al., 2007; Colecraft et al., 2001) . Assuming that VDF and CDF are mechanistically separable gating modes, the inhibition of VDF by BHQ may increase the availability of WT Ca v 2.1 channels to undergo CDF ( Figure 4E ). An alternate, although not mutually exclusive, explanation is suggested by the effects of BHQ on the S218L mutant. It has been proposed that the hyperpolarized shift in the voltage dependence of activation of S218L may cause these channels to be ''prefacilitated,'' so that they are not sensitive to Ca 2+ /CaM-stimulated transitions to the high P o gating mode (Adams et al., 2010) . By inhibiting voltage-dependent activation ( Figure 5H ; Table 1 ), BHQ may return a fraction of the mutant channels to the normal low P o gating mode so they can undergo CDF. An understanding of the mechanistic basis for how BHQ modulates CDF awaits detailed singlechannel analyses of I Ca and I Ba in WT and S218L channels.
In the absence of BHQ, we identified a slow component of deactivation that was significantly greater for I Ca mediated by S218L compared to WT channels ( Figure 6D ). Because CDF is associated with a broadening of tail I Ca during APW trains (Chaudhuri et al., 2007) , this difference may arise from the ''prefacilitated'' S218L channels. Although not noted previously, the $50% increase in the slow tail I Ca in S218L compared to WT channels ( Figure 6D ) would augment action-potential-driven neurotransmitter release and subsequently accelerate the development of synaptic depression. Indeed, compared to WT, EPSPs at the NMJ in S218L KI mice are of greater amplitude and show faster rundown at physiological firing frequency . Moreover, EPSPs at S218L KI NMJ are broader than in WT and often exhibit an irregular plateau during the falling phase . These results could be explained by the increased slow deactivation of S218L channels, which may cause abnormal prolongation of neurotransmitter release. Similar alterations in S218L deactivation at central synapses may contribute to the increased excitatory transmission and lower thresholds for cortical spreading depression, which is thought to underlie the headache symptoms associated with migraine (van den .
Dysregulation of CDF and Impaired Synaptic Plasticity
Caused by S218L CDF of presynaptic Ca v 2.1 channels has emerged as an important determinant of STF (Mochida et al., 2008) . At the parallel fiber-Purkinje cell synapse, STF is robust in WT but not in S218L KI mice (Adams et al., 2010) , which could be explained by reduced net CDF caused by the S218L mutation. However, a complicating factor is that increased Ca 2+ influx in parallel fiber terminals due to ''prefacilitated'' channels (Adams et al., 2010) would likely saturate the Ca 2+ sensor for exocytosis in S218L KI mice. This would decrease release probability, which itself would reduce STF. Our findings that BHQ restores not only CDF of S218L channels in HEK293T cells (Figure 7 ) but also STF at ''S218L'' NMJs ( Figure 9 ) indicate that dysregulation of , basal evoked EPSP amplitudes (mean ± SEM) were compared for control and BHQ in ''WT'' (left) and ''S218L'' (right). *p < 0.05 by t test. (E) Same as in (B) except that extracellular Ca 2+ was 1.5 mM. *p < 0.05 by t test.
See also Figure S5 .
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Modulation of Ca v 2.1 Gating by BHQ CDF contributes to the impaired synaptic plasticity caused by the S218L mutation. Given the localization of Ca v 2.1 channels at most central synapses (Westenbroek et al., 1995) , our results predict widespread deficits in short-term plasticity caused by the S218L mutation. Whether such alterations contribute to the neurological phenotypes associated with FHM-1 remains an important challenge for future studies.
Therapeutic Implications for Ca v 2.1 Channelopathies The CACNA1A gene encoding Ca v 2.1 channels is a major target of mutations that cause severe neurological disorders in humans (Pietrobon, 2010) . Significant advances have been made in understanding the pathogenic mechanisms associated with some of the mutations, thanks to the generation of appropriate KI mice (van den Maagdenberg et al., 2004 Watase et al., 2008) . Our study highlights the use of Drosophila as an alternate strategy to investigate the synaptic defects caused by CACNA1A mutations. The gain of function in EPSPs and impaired STF at the NMJs of ''S218L''-expressing flies ( Figures  8 and 9 ) are similar to that seen at the NMJs and parallel fiberPurkinje cell synapses, respectively, of S218L KI mice (Adams et al., 2010; Kaja et al., 2010) . Moreover, BHQ regulates synaptic transmission at ''WT'' and ''S218L'' NMJs in a manner consistent with its modulation of the corresponding channels in HEK293T cells. These results indicate that the incorporation of human mutations into the cacophony gene, and expression of the mutant construct in Drosophila motor neurons, can simulate the functional abnormalities associated with Ca v 2.1 channelopathies. This approach should prove useful in the search for pharmacological and genetic modifiers that can ameliorate the often severe neurophysiological consequences of CACNA1A mutations. Despite the known activity of BHQ on SERCAs and Ca v channels (Fusi et al., 2001; Moore et al., 1987; Scamps et al., 2000) , the effects of BHQ on synaptic transmission at the Drosophila NMJ could be explained largely by its modulation of Ca v 2.1. Due to its pro-oxidant effects and actions on targets other than Ca v 2.1, BHQ itself may not be therapeutically suitable as a specific gating modifier for neuronal Ca v 2.1 channels. However, the ability of BHQ to oppose the defects in Ca v 2.1 gating and synaptic transmission associated with the S218L mutation suggests that modification of the chemical structure of BHQ may yield small-molecule modulators that could selectively inhibit or enhance activation/deactivation gating of Ca v 2.1. Such compounds would greatly extend current capabilities to dissect the functions of Ca v 2.1 channels in normal and diseased states of the nervous system.
EXPERIMENTAL PROCEDURES Cell Culture and Transfection
The following Ca v subunit cDNAs were used: human WT a 1 2.1 (GenBank accession number NM_023035.1) or S218L mutant in pcDNA 3.1 Zeo (+) (generously provided by Dr. T. Snutch, described in Adams et al., 2010) , rat b 2a (GenBank accession number NM_053851), and rabbit a 2 d 1 (GenBank accession number M21948). HEK293T cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum (Life Technologies), penicillin (50 U/ml), and streptomycin (50 mg/ml) at 37 C in a humidified atmosphere with 5% CO 2 . Cells were grown to $80% confluency and transfected with Fugene 6 (Roche) according to the manufacturer's protocol. Cells were transfected with cDNAs encoding WT-a 1 2.1 or S218L-a 1 2.1 (1 mg), b 2a (0.5 mg), and a 2 d 1 (0.5 mg) with pEGFP-N1 (Life Technologies, 0.1 mg). Ca 2+ or Ba 2+ currents were recorded in transfected HEK293T cells in wholecell patch-clamp configuration at room temperature. Recordings were performed between 48 to 72 hr after transfection. Extracellular recording solutions contained 150 mM Tris, 1 mM MgCl 2 , and 10 mM CaCl 2 or 10 mM BaCl 2 . Intracellular recording solutions contained 140 mM N-methyl-D-glucamine, 10 mM HEPES, 2 mM MgCl 2 , 2 mM Mg-ATP, and 5 mM EGTA. The pH of extracellular and intracellular recording solutions were adjusted to 7.3 with methanesulfonic acid. Reagents used for electrophysiological recordings were obtained from Sigma-Aldrich. BHQ (Tocris Bioscience) was dissolved in DMSO at a concentration of 100 mM to make a stock solution. BHQ was diluted with the extracellular solution immediately before recording. For each cell, voltage protocols were run first under control conditions (0.01% DMSO) followed by extracellular perfusion with BHQ and finally on washout of BHQ with the control solution.
Electrophysiological Recordings of Transfected HEK293T Cells
Data from cells in which the effect of BHQ was reversible were included in the analysis. Recording electrodes were pulled from borosilicate glass (World Precision Instruments) on a Sutter P97 puller (Sutter Instruments). Electrode resistances in the recording solutions were typically 2-4 MU. Series resistance ranged from 4 to 6 MU and compensated at 50%-80%. Currents were recorded with an EPC-10 patch-clamp amplifier driven by PatchMaster software (HEKA Electronics). Leak current was subtracted using a P/8 protocol. Whole-cell currents were digitized at 50 kHz after filtering at 10 kHz. APWs were constructed by averaging traces corresponding to spontaneous action potentials recorded in current clamp from dissociated mouse Purkinje neurons (Kreiner et al., 2010) . Data were analyzed using routines written in IGOR Pro software (WaveMetrics). Averaged data represent the mean ± SEM. Statistical differences between groups were determined by Student's t test unless otherwise indicated. Tail 
where y 0 is the baseline, t is time, t 0 is initial time, and A is amplitude. The decay was fit over an interval long enough for the current to reach steady state in control and in the presence of BHQ. In comparisons of I Ca and I Ba evoked by single test pulses, results are compared at different voltages to account for the differences in voltage-dependent activation due to distinct surface charge screening effects of Ca 2+ and Ba 2+ (see V h in Table 1 ).
Measurements of Intracellular Ca 2+ Concentration
Transfected HEK293T cells were either incubated with Fura-2/AM or loaded with Fura-2 (Invitrogen) via the patch pipette (100 mM), which also contained the intracellular recording solution described for electrophysiological recordings. Cells were placed in a flowthrough chamber mounted on the stage of an inverted IX-71 microscope (Olympus). Fluorescence was alternately excited at 340 (12 nm bandpass) and 380 (12 nm bandpass) nm using the Polychrome IV monochromator (TILL Photonics) via a 403 oil-immersion objective (NA = 1.35, Olympus). Emitted fluorescence was collected at 510 nm (80 nm bandwidth) using an IMAGO CCD camera (TILL Photonics). Pairs of 340/ 380 nm images were sampled at 10 Hz. Fluorescence was corrected for background, as determined in an area that did not contain a cell. Data were processed using TILLvisION 4.0.1.2 (TILL Photonics) and presented as a fluorescence ratio of F 340 /F 380 , where F 340 and F 380 are fluorescence intensities at the excitation wavelengths 340 and 380 nm, respectively.
Electrophysiological Recordings of Drosophila NMJ
The cacophony transgenic line UAS-cac-EGFP 786c (Kawasaki et al., 2004) was expressed under control of the C155-GAL4 (elaV) driver (Lin and Goodman, 1994) as the ''WT'' condition. For the ''S218L'' condition, we used PCR to mutate the serine 161 codon in the UAS-cac-EGFP cDNA analogous to serine
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Modulation of Ca v 2.1 Gating by BHQ 218 of CACNA1A (Kawasaki et al., 2004) . The resulting cDNA was used to generate a UAS-cac-EGFP S/L transgene and expressed using the same C155-GAL4 driver. For electrophysiological recordings of NMJs, wandering third instar larvae were selected for analysis. Sharp electrode recordings were taken from muscle 6 of abdominal segments 2 and 3, as described elsewhere (Davis et al., 1998; Frank et al., 2006 Frank et al., , 2009 . Larvae were dissected in a modified HL3 saline with the following components (and concentrations): NaCl (70 mM), KCl (5 mM), MgCl 2 (10 mM), NaHCO 3 (10 mM), sucrose (115 mM = 3.9%), trehalose (4.2 mM = 0.16%), HEPES (5.0 mM = 0.12%), and CaCl 2 (0.4 mM, unless otherwise indicated). Data were collected using an Axopatch 200B electrode amplifier (Molecular Devices), digitized using a Digidata 1440A data acquisition system (Molecular Devices), and recorded with pCLAMP 10 acquisition software (Molecular Devices). For presynaptic nerve stimulation, a Master-8 pulse stimulator (A.M.P. Instruments) and an ISO-Flex isolation unit (A.M.P. Instruments) were utilized to deliver stimuli to the nerve (1-ms stimulus duration).
A custom function was written in Igor Pro for amplitude analysis of trains of EPSPs evoked at the NMJ. For each EPSP, a single exponential was used to fit the decay of the EPSP peak to the start of the next EPSP. The exponential decay was then extrapolated to the time point of the subsequent peak response. This point was used as the baseline for peak amplitude measurements of EPSPs 2-50. The first EPSP peak amplitude was simply the baseline measured before the train subtracted from the first peak. Two to four trains were evoked per muscle. The EPSP amplitudes measured by the aforementioned procedure were then averaged. These averaged amplitudes were then normalized to the first averaged EPSP amplitude to yield F ratio values for each muscle so that the SE for F ratio plotted in Figure 9 represents the variability between muscles. Averaged data represent mean ± SEM from four to six animals per genotype.
NMJ Analyses by Immunocytochemistry
Dissected third instar larvae were fixed for 2-4 min in Bouin's fixative (Ricca Chemical Company or Sigma-Aldrich), washed with PBS and PBS + 0.1% Tween-20 (PBT), and incubated overnight at 4 C with primary antibodies. After three washes in PBT, secondary antibodies were applied for 2 hr at room temperature. The following primary antibodies were used: mouse anti-Synapsin, 1:50 (Developmental Studies Hybridoma Bank [DSHB], University of Iowa; Klagges et al., 1996) , mouse anti-Bruchpilot, 1:250 (DSHB; Wagh et al., 2006) , rabbit anti-GluRIIC, 1:3,000 (Marrus and DiAntonio, 2004) , and rabbit anti-Dlg, 1:3,000 (Budnik et al., 1996) . Fluorophore-conjugated goat antimouse and goat anti-rabbit secondary antibodies were used (Jackson Immunoresearch Laboratories). 
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